Ireland· IE-PA-EU/1/10/645/001-002
BRINAVESS 20 mg/ml concentrate for solution for infusion
A vernakalant product containing vernakalant hydrochloride, registered in Ireland by Correvio. The same ATC class is registered in 12 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Vernakalant is registered in 12 of 19 countries.
Countries holding a registration under ATC C01BG11 (vernakalant), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 7 of them publish a price we can compare per daily dose
Vernakalant · ATC C01BG11
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
The record
At a glance
HPRA (Ireland)- Active substance
- Vernakalant hydrochloride
- Manufacturer
- Correvio
- Country
- Ireland (IE)
- ATC code
- C01BG11
- ATC class
- Vernakalant
- Defined daily dose
- 0.2 g, P
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/10/645/001-002
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Vernakalant in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumBrinavess 20 mg/mlAdvanz Pharma
- CzechiaBRINAVESSADVANZ PHARMA Limited, Dublin
- FinlandBRINAVESSAdvanz Pharma Limited
- IcelandBrinavessADVANZ PHARMA Limited
- PolandBrinavessCorrevio
- SwedenBRINAVESS 20 mg/ml Koncentrat till infusionsvätska, lösningAdvanz Pharma Limited
- SpainBRINAVESS 20 mg/ml, CONCENTRADO PARA SOLUCION PARA PERFUSIONAdvanz Pharma Limited
- United KingdomBrinavess 500mg/25ml concentrate for solution for infusion vialsAdvanz Pharma
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Brinavess
- Liechtenstein · Brinavess
- Norway · Brinavess
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/49040516-95ae-49e0-bd1e-bee28eeba592 GET /v1/drugs/49040516-95ae-49e0-bd1e-bee28eeba592?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Concentrate for solution for infusion",
"routes": [
"Intravenous use"
],
"source": "hpra",
"atc_all": [
"C01BG",
"C01BG11"
],
"strength": null,
"pa_number": "EU/1/10/645/001-002",
"substances": [
"Vernakalant hydrochloride"
],
"legal_basis": "New active substance (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "01/09/2010",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about vernakalant.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.